Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» hemophilia A
hemophilia A
BioMarin's Novel Treatment Promises to Disrupt Competitors
Motley Fool
Wed, 02/26/20 - 10:45 am
Biomarin
gene therapy
valrox
hemophilia A
FDA Gives BioMarin Pharmaceuticals' Hemophilia Gene Therapy Priority Review
Motley Fool
Thu, 02/20/20 - 11:41 pm
FDA
Biomarin
priority review
valrox
gene therapy
hemophilia A
Novimmune unit nabs Takeda milestone payment for hemophilia work
Fierce Biotech
Fri, 02/14/20 - 10:40 am
Takeda
Light Chain Bioscience
Novimmune
R&D
Hemlibra
hemophilia A
Drugmaker BioMarin Seeks New CFO Amid Coming Release Of Potentially Costliest Drug In The World
Forbes
Thu, 02/6/20 - 11:37 pm
Biomarin
valrox
gene therapy
hemophilia A
Takeda Eyes 12 New Drug Approvals by 2024, Hemophilia Gene Therapy May Not be a Competitor
BioSpace
Wed, 01/22/20 - 11:08 am
Takeda
drug approvals
hemophilia A
TAK-754
TAK-748
Generation Bio grabs a $110M round to ramp up work on next-gen gene therapies
Fierce Biotech
Fri, 01/10/20 - 10:40 am
Generation Bio
hemophilia A
phenylketonuria
gene therapies
Value-based pricing for gene therapy? Maybe not ready for hemophilia
Biopharma Dive
Thu, 12/12/19 - 10:52 am
Biomarin
hemophilia
hemophilia A
gene therapy
valoctocogene roxaparvovec
uniQure
hemophilia B
etranadez
Sigilon Therapeutics approaches the clinic
EP Vantage
Thu, 09/19/19 - 08:11 pm
Sigilon
orphan drug
hemophilia A
Eli Lilly
diabetes
BioMarin talks down worries on gene therapy data differences
Biopharma Dive
Tue, 09/10/19 - 11:39 pm
Biomarin
gene therapy
hemophilia A
valrox
BioMarin drops lower dose of its hemophilia gene therapy as it eyes submissions by year-end
Fierce Biotech
Fri, 08/2/19 - 10:37 am
Biomarin
hemophilia
gene therapy
valoctocogene roxaparvovec
valrox
hemophilia A
Bayer recalls mislabeled vials of hemophilia A treatment
Fierce Pharma
Tue, 07/23/19 - 10:12 am
Bayer
product recalls
hemophilia A
Kogenate FS
Jivi
Billions on the line: BioMarin bustles past enthused rival, planning to launch world’s first hemophilia A gene therapy
Endpoints
Mon, 07/8/19 - 08:13 pm
Biomarin
hemophilia A
gene therapy
FDA
Sangamo
Pfizer
Sangamo backs up early success for hemophilia gene therapy
Biopharma Dive
Sat, 07/6/19 - 01:36 pm
Sangamo
gene therapy
hemophilia A
SB-525
Pfizer
Spark Therapeutics
Biomarin
How BioMarin May Revolutionize the Hemophilia Treatment Market
Motley Fool
Tue, 05/28/19 - 11:25 pm
Biomarin
gene therapy
hemophilia A
valrox
Does Sangamo Have the Best Gene Therapy Program Now?
Motley Fool
Wed, 04/3/19 - 12:28 pm
Sangamo Therapeutics
gene therapy
SB-525
hemophilia A
15 For ’19: Key Clinical Data To Watch For Next Year (Part 1)
Xconomy
Mon, 12/17/18 - 09:44 am
clinical trials
Alzheimer's disease
Biogen
Duchenne Muscular Dystrophy
Pfizer
Solid Biosciences
Sarepta Therapeutics
hemophilia A
Biomarin
Multiple Myeloma
Celgene
Bluebird Bio
Amgen
solid tumors
Bristol-Myers Squibb
Nektar Therapeutics
age-related macular degeneration
Regenxbio
SAGE Therapeutics
MorphoSys
FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom
Xconomy
Thu, 10/4/18 - 06:52 pm
hemophilia A
FDA
Roche
Hemlibra
Roche reveals haemophilia drug data ahead of label expansion decision
Pharmaforum
Fri, 08/31/18 - 11:51 am
Roche
hemophilia A
FDA
Hemlibra
Bayer Secures FDA Approval for Hemophilia A Treatment, Jivi
BioSpace
Thu, 08/30/18 - 10:13 am
hemophilia A
Bayer
FDA
Jivi
BAY94-9027
Spark’s gene therapy data answer some burning questions — and raise a few more
Stat
Tue, 08/7/18 - 11:42 am
Spark Therapeutcs
hemophilia A
Factor VIII
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »